Elicio Therapeutics, Inc. (ELTX) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-02-03

Elicio Therapeutics, Inc. (ELTX) — no SEC Form 4 insider filings recorded in the last 90 days. 6 Form 8-K material event filings were reported by ELTX in the last 90 days. InsiderAlpha tracks every ELTX SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Elicio Therapeutics, Inc. (ELTX)

SEC CIK	0001601485

90-Day SEC Filing Activity

Form 8-K filings (90d)	6
Latest Form 4 filing	2026-02-03

Recent ELTX Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-02-02	Connelly Robert	CEO, President and Director	A — Grant or award	73.6K	$0.00	—	SEC
2026-02-02	Shah Preetam	See Remarks	A — Grant or award	24.0K	$0.00	—	SEC
2026-02-02	DeMuth Peter	Chief Scientific Officer	A — Grant or award	20.8K	$0.00	—	SEC
2026-02-02	Haqq Christopher	See Remarks	A — Grant or award	25.4K	$0.00	—	SEC
2024-12-16	DeMuth Peter	Chief Scientific Officer	M — Option exercise	381	$4.41	$2K	SEC
2024-11-26	Venkatesan Jay	Director	J — Other acquisition / disposition	50.0K	$0.01	$500	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Elicio Therapeutics, Inc. (ELTX). Updated in real time as new filings are submitted to the SEC.

Recent ELTX Form 8-K Material Events

2026-07-02 — Item 1.01, 8.01, 9.01 [SEC]
2026-06-24 — Item 7.01 [SEC]
2026-06-17 — Item 8.01 [SEC]
2026-06-15 — Item 8.01 [SEC]
2026-06-15 — Other · neutral [SEC]
Trading halt (T1) for ELTX. ELTX

Recent Insider Filings

2026-02-03 — Connelly Robert (CEO, President and Director)
2026-02-03 — Shah Preetam (See Remarks)
2026-02-03 — DeMuth Peter (Chief Scientific Officer)
2026-02-03 — Haqq Christopher (See Remarks)
2025-05-19 — WILSON KAREN J (Director)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ELTX insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ELTX Insider Trading — FAQ

What is the latest insider trade for ELTX?: Elicio Therapeutics, Inc. (ELTX) had 0 insider filings in the last 90 days, with the most recent on 2026-02-03. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ELTX stock?: 0 insider purchases of ELTX were filed in the last 90 days.
How many insiders are selling ELTX stock?: 0 insider sales of ELTX were filed in the last 90 days.
Where can I see ELTX SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ELTX SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ELTX dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.